RT Journal
T1 Incorrect residual heparin amount in: Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the time randomized trial
JF JAMA
JO JAMA
YR 2013
FD January 23
VO 309
IS 4
SP 343
OP 343
DO 10.1001/jama.2012.196454
UL http://dx.doi.org/10.1001/jama.2012.196454
AB 
Incorrect Residual Heparin Amount:  In the Original Contribution entitled “Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction: The TIME Randomized Trial,” published in the December 12, 2012, issue of JAMA (2012;308[22]:2380-2389), under the Results heading, third full paragraph, the third sentence should have stated, “The cell product was devoid of significant red blood cell contamination, contained only minuscule amounts of heparin (estimated at 0.01 U/mL), and most participants were infused within 1 hour of completion of cell processing,11 thereby avoiding concerns recently expressed in the literature.12,13” This article has been corrected online.